SUMO-1 Mutant Protein Set

貨號 Cat. No.
K-712
規格 Size
1 kit
品牌 Brand
Boston Biochem

Description

SUMO-1 Mutant Protein Set

Catalog #: K-712




SUMO-1 Mutant Protein Set






Product Source: 

human recombinant



The ubiquitin-like SUMO-1, SUMO-2 and SUMO3 proteins are conjugated to a variety of proteins in the presence of UbcH9 and the SAE1/SAE2 (human) or Aos1/Uba2 (yeast) activating enzyme. SUMO modification has been implicated in diverse functions such as nuclear transport, chromosome segregation and transcriptional regulation, apoptosis and protein stability. Human SUMO-1 shares 46% and 47% identity with SUMO-2 and SUMO-3 respectively and does not contain the exact ψΚXE consensus sequence found in SUMO-2 and SUMO-3. Within this sequence ψ represents a large hydrophobic amino acid (I, L, or V), K is the lysine that becomes modified, X is any residue and E is glutamic acid. Many known SUMO-1 conjugation sites occur within this motif, but SUMOylation also occurs on lysine residues located within non-consensus regions. SUMO-1 has been shown to form chains in vitro and in vivo but often the linkage is uncharacterized, and the function of SUMO chains has not yet been fully elucidated. SUMO-1 multimerization in vitro has been shown to occur predominantly via K7, K16 and K17. The proteins in this kit have these lysine residues mutated to arginine and can be used to investigate mono-SUMOylation requirements or to reduce poly-SUMO chain formation. Included is wild-type SUMO-1 to be used as a positive control in SUMO-1 conjugation assays which can be performed using the SUMO-1 Conjugation Kit (K-710).


Product Information



Quantity: 

1 kit






Stock: 

50mM HEPES pH 8.0, 150mM NaCl, 1 mM DTT.






Purity: 

> 95 % by SDS-PAGE






Supplied: 


























































Protein

MW Concentration Quantity

SUMO-1 wildtype

11.1 kDa X mg/ml (X μM) 50 μg

SUMO-1 K7R

11.1 kDa X mg/ml (X μM) 50 μg
SUMO-1 K16R

 
11.1 kDa X mg/ml (X μM) 50 μg
SUMO-1 K17R 11.1 kDa  X mg/ml (X μM) 50 μg
SUMO-1 K7R K16R 11.1 kDa X mg/ml (X μM) 50 μg
 SUMO-1 K7R K17R 11.1 kDa X mg/ml (X μM)  50 μg
 SUMO-1 K16R K17R 11.1 kDa X mg/ml (X μM)  50 μg
SUMO-1 K7R K16R K17R 11.1 kDa X mg/ml (X μM) 50 μg





 





Background: 

The ubiquitin-like SUMO-1 is conjugated to a variety of proteins in the presence of UbcH9 and the SUMO E1 activating enzyme (SAE1/SAE2 in human, or Aos1/Uba2p in yeast). The heterodimeric SAE1/SAE2 complex (38 and 70 kDa respectively) uses ATP to adenylate the C-terminal glycine

residue of SUMO-1, forming a high-energy thiolester bond with the SAE2 subunit. The second step is the trans-esterification reaction whereby the activated SUMO-1 is transferred to Cys93 of UbcH9. UbcH9 is a member of the E2 family and is homologous to ubiquitin conjugating enzymes, but is

specific for the conjugation of SUMO to a variety of target proteins. This E2 is unusual in that it interacts directly with protein substrates that are modified by sumolyation, and may play a role in substrate recognition. Sumoylated substrates are primarily localized to thenucleus (RanGAP-1, RANBP2, PML, p53, Sp100, HIPK2) but there are also cytosolic substrates (IκBα, GLUT1, GLUT4). SUMO modification has been implicated in functions such as nuclear transport, chromosome segregation and transcriptional regulation, apoptosis and protein function and stability.





Use & Storage



Use: 

Typical concentration to support conjugation reaction in vitro is 10 μM-50 μM depending on conditions.






Storage: 

Store at -80°C. Avoid multiple freeze/thaw cycles.



詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢